*** David Sobek is a disciplined value investor. Using models, research, and fundamental data, David devises a value for biotech stocks, buys when significantly undervalued, and sells when significantly overvalued.*** As a reminder, this is my personal guide. You can alter it in accordance with your risk tolerance. >3 Standard deviations – No position 2-3 […]
Catatonic Economics – Brexit!
In response to Dave, “someone will nail the impact”… I figured I’d give my shot at it. My prediction last article was that sovereign debt along with other headwinds would cause a correction in the markets before year’s end. It took a lot shorter than I thought it would, and admittedly not for the reasons […]
Dave-Trading – June Edition
*** David Sobek is a disciplined value investor. Using models, research, and fundamental data, David devises a value for biotech stocks, buys when significantly undervalued, and sells when significantly overvalued.*** As a reminder, this is my personal guide. You can alter it in accordance with your risk tolerance. >3 Standard deviations – No position 2-3 […]
Cup O' Joe – SRPT followup
***Joe Gantoss relies on knowing more, either through technical analysis & charts or DD & research.*** Last article, I spoke about the decision tree, and how to play the coming SRPT decision. This is a follow-up, since some important information was disclosed since that trade. The first piece of information is that SRPT received a […]
Catatonic Economics – The Four Letter Word
*** “The market can remain irrational longer than you can remain solvent” – John Maynard Keynes *** Economics is called the dismal science for a reason. The real reason is because Thomas Malthus predicted that the population will grow exponentially while food can only grow additively, and therefore the world will be overpopulated in short […]
Cup O’ Joe – May SRPT Edition
***Joe Gantoss relies on knowing more, either through technical analysis & charts or DD & research.*** Well, SRPT has delayed their decision past the PDUFA, destroying the weekly out-of-the-money (OTM) options traders counting on a decision. I debated making a play, but ultimately I was not comfortable. But that trade is over, where do we […]
Dave-Trading – May edition
*** David Sobek is a disciplined value investor. Using models, research, and fundamental data, David devises a value for biotech stocks, buys when significantly undervalued, and sells when significantly overvalued.*** As a reminder, this is my personal guide. You can alter it in accordance with your risk tolerance. >3 Standard deviations – No position 2-3 […]
Buy DeLo, Sell DeHigh – GILD Earnings
Last week I tweeted about an options play I made on $GILD earnings. I consulted with Dave, who said he was not expecting much of a move. The options were pricing a large move, so I made a lotto play. It was a 5-wide butterfly that cost me $250. As you can see from the […]
Catatonic Economics – Nippon!
*** “I’m turning Japanese, I think I’m turning Japanese, I really think so.” – Janet Yellen *** All right, so maybe Janet Yellen didn’t say that outside a karaoke bar… but she is turning Japanese monetary policy! (Song by “The Vapors”, have to give credit where it is due) On April 28th, the […]
Dave-Trading – April Edition
*** David Sobek is a disciplined value investor. Using models, research, and fundamental data, David devises a value for biotech stocks, buys when significantly undervalued, and sells when significantly overvalued.*** As a reminder, this is my personal guide. You can alter it in accordance with your risk tolerance. >3 Standard deviations – No positionPreview 2-3 […]
Catatonic Economics
***”Economists have forecast 9 out of the last 5 recessions. *** One contribution I make to the CRG team is my background in economics. I have a pervasive interest in macroeconomics and am close to getting my Masters in Economics. I have worked for an economic indicator at the US Census Bureau, and work as […]
Cup O' Joe – GILD Calls
***Joe Gantoss relies on knowing more, either through technical analysis & charts or DD & research.*** Thesis: GILD has been in a channel between ~87 and ~91. Joe already has Apr. GILD $100 calls. To finish in the money, Joe needs an 11% move upward in 28 days. The time decay on these options […]
Dave-Trading BIIB
*** David Sobek is a disciplined value investor. Using models, research, and fundamental data, David devises a value for biotech stocks, buys when significantly undervalued, and sells when significantly overvalued.*** Before we get to the meat of the trade, I want to address a recent question. How do I know how much capital to […]
Buy DeLo, Sell DeHigh – RUT
*** Jason DeLorenzo is an income options trader. He trades on indexes mostly, but will trade positions based on CRG theses*** On 2/18 close to the market close, Joe tweeted this: “Joe @GantosJ Feb 18: The “Three Gaps Up” pattern $SPY $IBB $XBI is only a warning that exhaustion in the way, BUT expanding […]
Dave-Trading – GILD
Gilead – GILD *** David Sobek is a disciplined value investor. Using models, research, and fundamental data, David devises a value for biotech stocks, buys when significantly undervalued, and sells when significantly overvalued.*** Dave LOVES writing about GILD. Their combined Hep C franchise is by all metrics the most successful launch ever, so it is […]
Options Basics (4) – Options Strategies
So far, we discussed all the essential option characteristics. What an option is, its variables, and how to use options for risk adjustment. So now that you know these things, there are several “goto” strategies that take advantage of the flexibility of options. These are general strategies, and not specific to a trade. When […]
Dave-Trading – PFE
Pfizer Inc. (PFE)–NYSE *** David Sobek is a disciplined value investor. Using models, research, and fundamental data, David devises a value for biotech stocks, buys when significantly undervalued, and sells when significantly overvalued.*** Options are unfairly seen as risky, and many value investors avoid options out of fear. David Sobek appears to be […]
Options Basics (3) – Options variables and Greeks
We already discussed what an option is, and how it can help with risk management. When I was talking about risk management, I was talking about how options require a lot less margin to make the same amount of money on a stock. Why wouldn’t everyone do it then? In short, it is because there are […]
Cup O' Joe – SRPT AdCom
***Our trading analyst Joe Gantoss relies on knowing more, either through technical analysis & charts or DD & research.*** Thesis: Joe has done a lot of research on SRPT. Despite some FDA headwinds, he believes the AdCom will at least be moderately positive for SRPT. But there is some downside risk, so there is […]
Options Basics (2) – Options as a risk management tool
In the last article, I discussed the basics of options. What they are, their classification, properties, and the different types that exist. I also mentioned how options allow you to speculate on the most expensive stocks at the price of a penny stock. This can make the prudent investor uncomfortable, as penny stocks are […]
